Luke Brzozowski
Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics UHN
Dr. Luke Brzozowski is the Executive Director of Theranostics and Core Facilities at UHN. In this role, he serves as the executive sponsor for the Theranostics Program and oversees a portfolio of 23 core facilities, along with several large-scale innovation programs.
In recent years, Luke has also served as President of the Board for CanProbe, a startup specializing in molecular imaging and theranostics. Before joining UHN, he held leadership positions across development, marketing, legal, and regulatory departments in the health technology industry and pharmaceutical contract research organization (CRO).
Luke earned his Doctorate in nanotechnology and nonlinear optics from the University of Toronto and was awarded the prestigious 2003 Governor General’s Gold Medal for his research excellence.
Seminars
- Establishing integrated theranostics programmes that support translational research and clinical delivery
- Aligning imaging, clinical and operational expertise to accelerate radiopharmaceutical development
- Creating collaborative ecosystems that enable innovation from bench to bedside
- Identifying the key barriers to integrating radiopharmaceuticals into standard care, including governance, funding models, regulatory frameworks, and system complexity
- Exploring how healthcare systems, industry, and regulators can collaborate to enable coordinated, scalable integration within existing constraints
- Assessing the infrastructure, workforce, and operational capacity required to support demand, including planning for variability between projected and real-world volumes
